Back to news

Kia Ora, 
As you will be aware, New Zealand will be moving into phase 3 of the Omicron response on Thursday 24 Friday at 11.59 pm.
We acknowledge that the increasing number of Omicron cases in the community will pose some challenges.  We will continue to work hard to ensure we are able to deliver safe and timely care over the coming weeks.  Thank you for working with us to ensure we can maintain your safety and the safety of our teams. 
Our teams will be using appropriate personal protective equipment and are all fully vaccinated.

We continue to use many elements of our Covid-safe framework to ensure we are able to keep you and our teams safe.

We will need your help to maximise safety.  This means:

•    You MUST wear a medical-grade mask when you are in our facilities.  (If you do not have a mask, our teams will be able to provide you with one). 

•    We are maximising physical distancing on our sites.  You may be asked to wait outside or in your car until we call you for your scan. 

•    We are limiting visitors/support people on our sites.  Where there are exceptional circumstances, support people must be vaccinated, and they will be required to show their vaccine pass.

•    We will still be conducting patient screening, so you will be asked to complete a questionnaire before your scan. 

•    Depending on what scan or procedure you have with us, you may be asked to complete a Rapid Antigen Test which we will supply before your scan or procedure.  If your result is positive, we may need to rebook your appointment. 

•    If you are unwell, please contact us to reschedule your appointment.

​​​​​•    All of our sites have other healthcare providers co-located, and there may be increased congestion in these areas.  We encourage you to arrive early to find parking.

Our aim is to ensure you are as safe as possible when you visit our facilities and that we're also able to keep our teams as safe as possible. 

Thank you for your ongoing support and your patience. 

Ngā mihi nui.      

Dr Lloyd McCann 


Back to news